STEM-CELL THERAPY FOR TYPE 1 DIABETES REDUCED PATIENT’S INSULIN NEEDS BY 91%

[Northerner]

The first patient dosed with VX-880 — a stem cell-derived potential therapy to treat Type 1 diabetes — has experienced a 91% decrease in their daily insulin doses, according to a recent press release.

In Phase 1/2 of its clinical trial, Vertex Pharmaceuticals Incorporated shared the staggering results after only 90 days of its ongoing investigational study, with the patient’s insulin needs reducing from 34 daily units down to 3 daily units.

VX-880 is manufactured using proprietary technology from Vertex Pharmaceuticals, a global biotechnology company that has multiple FDA-approved medications for cystic fibrosis. With their sights set on a breakthrough treatment for people with Type 1 diabetes, VX-880 is stem cell therapy approach that aims to restore insulin production and stable blood sugar levels.

Stem-Cell Therapy for Type 1 Diabetes Reduced Patient's Insulin Needs by 91%

The early results of a clinical trial using stem-cell therapy to treat type 1 diabetes reduced the patient’s insulin needs by 91%.

beyondtype1.org

 

[nonethewiser]

The first patient dosed with VX-880 — a stem cell-derived potential therapy to treat Type 1 diabetes — has experienced a 91% decrease in their daily insulin doses, according to a recent press release.

In Phase 1/2 of its clinical trial, Vertex Pharmaceuticals Incorporated shared the staggering results after only 90 days of its ongoing investigational study, with the patient’s insulin needs reducing from 34 daily units down to 3 daily units.

VX-880 is manufactured using proprietary technology from Vertex Pharmaceuticals, a global biotechnology company that has multiple FDA-approved medications for cystic fibrosis. With their sights set on a breakthrough treatment for people with Type 1 diabetes, VX-880 is stem cell therapy approach that aims to restore insulin production and stable blood sugar levels.

Stem-Cell Therapy for Type 1 Diabetes Reduced Patient's Insulin Needs by 91%

The early results of a clinical trial using stem-cell therapy to treat type 1 diabetes reduced the patient’s insulin needs by 91%.

beyondtype1.org

Will have to put name down, like sound of that.

 

[Inka]

That sounds exciting 😎 Fingers crossed that one day very soon something like this works - and works reliably and without side-effects.

 

[Inka]

That sounds like progress. What do you think the 'immunosuppression therapy' involves?

Yeah, that’s the bad bit. I guess it’s similar to other transplanted things, but probably less of an onerous regime. That’s why I’d hold out for encapsulation personally.

 

[Robin]

That sounds like progress. What do you think the 'immunosuppression therapy' involves?

That’s always the downside of these things, isn’t it. How do you stop the body rejecting the stem cells, or attacking itself as it did before.